HomeNews & EventsEvents
to the archive
+49 531 6181-1404
+49 531 6181-1499
Already at the end of the 19th century, doctors observed that the tumour in some cancer patients shrank if the patients suffered from a bacterial infection with a high fever. These findings sparked interest in immunotherapy for cancer. Immunomodulatory treatments can specifically stimulate the immune system. As a result, the body’s own immune system is supported in its fight…
Prof Carlos A. Guzmán, head of the HZI department “Vaccinology and Applied Microbiology”, together with his team developed the adjuvant c-di-AMP, which is incorporated in the TherVacB vaccine. “We will not only contribute c-di-AMP but also our expertise in order to assist in preparing the clinical trial dossiers and obtaining regulatory approval,” says Guzman.
The vaccine will be…
Scientists of the Department "Epidemiology" at the HZI lead by Prof Gérard Krause together with German and international partners developed the mobile information system SORMAS. The system operates as an application on mobile phones and is particularly suitable for use in regions with weak infrastructure. SORMAS can record local data on disease outbreaks and transmit it to health…